Jordi Tomàs-Roig

493 total citations
15 papers, 369 citations indexed

About

Jordi Tomàs-Roig is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Jordi Tomàs-Roig has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Jordi Tomàs-Roig's work include Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Jordi Tomàs-Roig is often cited by papers focused on Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Neurogenesis and neuroplasticity mechanisms (4 papers). Jordi Tomàs-Roig collaborates with scholars based in Spain, Germany and Italy. Jordi Tomàs-Roig's co-authors include Ursula Havemann‐Reinecke, Ester Quintana, Fabiana Piscitelli, Lluís Ramió‐Torrentà, Luisa María Villar, María Muñoz‐San Martín, Vincenzo Di Marzo, Sigrid Hoyer‐Fender, René Robles‐Cedeño and María Buxó and has published in prestigious journals such as PLoS ONE, Scientific Reports and Brain Research.

In The Last Decade

Jordi Tomàs-Roig

14 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Tomàs-Roig Spain 10 152 98 90 69 61 15 369
Andrea L. Johnstone United States 15 405 2.7× 30 0.3× 76 0.8× 37 0.5× 43 0.7× 21 596
Ben Rombaut Netherlands 9 203 1.3× 46 0.5× 37 0.4× 34 0.5× 44 0.7× 12 315
Handojo Kusumo United States 8 157 1.0× 33 0.3× 77 0.9× 22 0.3× 22 0.4× 11 341
Chitra Joseph Australia 7 141 0.9× 21 0.2× 82 0.9× 31 0.4× 18 0.3× 9 370
Gláucia Monteiro de Castro Brazil 12 102 0.7× 21 0.2× 79 0.9× 61 0.9× 31 0.5× 20 394
Till S. Zimmer Netherlands 14 127 0.8× 85 0.9× 151 1.7× 13 0.2× 28 0.5× 22 431
Donna J. Messersmith United States 8 141 0.9× 24 0.2× 153 1.7× 42 0.6× 23 0.4× 12 357
Deborah J.R. Hankey United Kingdom 8 138 0.9× 278 2.8× 170 1.9× 150 2.2× 19 0.3× 9 628
Baole Zhang China 13 240 1.6× 19 0.2× 73 0.8× 20 0.3× 98 1.6× 29 436
Erika Lorenzetto Italy 13 159 1.0× 28 0.3× 149 1.7× 12 0.2× 26 0.4× 16 362

Countries citing papers authored by Jordi Tomàs-Roig

Since Specialization
Citations

This map shows the geographic impact of Jordi Tomàs-Roig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Tomàs-Roig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Tomàs-Roig more than expected).

Fields of papers citing papers by Jordi Tomàs-Roig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Tomàs-Roig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Tomàs-Roig. The network helps show where Jordi Tomàs-Roig may publish in the future.

Co-authorship network of co-authors of Jordi Tomàs-Roig

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Tomàs-Roig. A scholar is included among the top collaborators of Jordi Tomàs-Roig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Tomàs-Roig. Jordi Tomàs-Roig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Tomàs-Roig, Jordi, et al.. (2020). Dose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insult. Scientific Reports. 10(1). 590–590. 22 indexed citations
3.
Tomàs-Roig, Jordi, et al.. (2020). Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients. Journal of Neuroinflammation. 17(1). 21–21. 51 indexed citations
4.
Martín, María Muñoz‐San, René Robles‐Cedeño, María Buxó, et al.. (2019). Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions. Journal of Neuroinflammation. 16(1). 220–220. 63 indexed citations
5.
Tomàs-Roig, Jordi, Margarita Torrente, María Cabré, Elisabet Vilella, & María Teresa Colomina. (2019). Long lasting behavioural effects on cuprizone fed mice after neurotoxicant withdrawal. Behavioural Brain Research. 363. 38–44. 7 indexed citations
6.
Tomàs-Roig, Jordi, et al.. (2019). Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis. Frontiers in Genetics. 10. 1138–1138. 7 indexed citations
7.
Tomàs-Roig, Jordi & Ursula Havemann‐Reinecke. (2018). Gene expression signature in brain regions exposed to long-term psychosocial stress following acute challenge with cannabinoid drugs. Psychoneuroendocrinology. 102. 1–8. 9 indexed citations
8.
Tomàs-Roig, Jordi, Fabiana Piscitelli, Vanessa Gil, et al.. (2018). Effects of repeated long‐term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders. CNS Neuroscience & Therapeutics. 24(6). 528–538. 11 indexed citations
9.
Quintana, Ester, Clàudia Coll, María Muñoz‐San Martín, et al.. (2018). Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3‐like 1 and neurofilament light chain. European Journal of Neurology. 25(9). 1189–1191. 57 indexed citations
10.
Tomàs-Roig, Jordi, Eva Benito, Roberto Carlos Agís‐Balboa, et al.. (2016). Chronic exposure to cannabinoids during adolescence causes long‐lasting behavioral deficits in adult mice. Addiction Biology. 22(6). 1778–1789. 48 indexed citations
11.
Tomàs-Roig, Jordi, Fabiana Piscitelli, Vanessa Gil, et al.. (2016). Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in mice. Behavioural Brain Research. 303. 34–43. 18 indexed citations
12.
Tomàs-Roig, Jordi, Oliver Wirths, Gabriela Salinas, & Ursula Havemann‐Reinecke. (2016). The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone‐Induced Central Nervous System Demyelination. CNS Neuroscience & Therapeutics. 22(5). 387–395. 26 indexed citations
13.
Roig, Bárbara, Neus Franco‐Pons, Lourdes Martorell, et al.. (2010). Expression of the tyrosine kinase discoidin domain receptor 1 (DDR1) in human central nervous system myelin. Brain Research. 1336. 22–29. 27 indexed citations
14.
Franco‐Pons, Neus, Jordi Tomàs-Roig, Bárbara Roig, et al.. (2008). Discoidin Domain Receptor 1, a Tyrosine Kinase Receptor, is Upregulated in an Experimental Model of Remyelination and During Oligodendrocyte Differentiation In Vitro. Journal of Molecular Neuroscience. 38(1). 2–11. 18 indexed citations
15.
Gómez‐Arbonés, Xavier, et al.. (2004). Short CommunicationsA cardiological web as an adjunct to medical teaching: prospective analysis. Medical Teacher. 26(2). 187–189. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026